Press Releases for REGN

Press Releases
Regeneron Announces Presentation at the 29th Annual Canaccord Adams Global Growth Conference
BioMed Realty Trust Commemorates Five-Year Anniversary As a Public Company ; Ringing NYSE Closing Bell(R) Today; Provides Tenant Update
Regeneron Reports Second Quarter 2009 Financial and Operating Results
Regeneron Receives European Medicines Agency Positive Opinion for Marketing Authorization of Rilonacept for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
First Patient Enrolled in Regeneron and Bayer HealthCare VEGF Trap-Eye Phase 3 Program in Central Retinal Vein Occlusion
Sanofi-aventis and Regeneron Announce Results from Phase 2 Study with Aflibercept (VEGF Trap) in Advanced Ovarian Cancer Patients with Recurrent Symptomatic Malignant Ascites
Regeneron Converts Interleukin-1 Antibody Opt-In Rights to Royalty Agreement
Regeneron Announces Presentation at the 8th Annual Needham Life Sciences Conference
Regeneron Announces Presentation at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference
Regeneron Announces Presentation at the Deutsche Bank 34th Annual Healthcare Conference
Regeneron Reports First Quarter 2009 Financial and Operating Results
Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
Regeneron and The University of Texas Southwestern Medical Center at Dallas Enter Into a Strategic VelocImmune(® )Agreement to Discover Human Monoclonal Antibodies
Regeneron Announces Initiation of Phase 3 Gout Program with ARCALYST® (rilonacept)
Regeneron Announces Presentation at the Cowen and Company 29th Annual Healthcare Conference
Regeneron Announces Presentation at the Barclays Capital Global Healthcare Conference
Regeneron Reports Full Year and Fourth Quarter 2008 Financial and Operating Results
Novel Search Strategies to Be Presented By NextBio at the Molecular Medicine Tri-Conference - Feb 24 2009 11:55PM
Novel Search Strategies to Be Presented By NextBio at the Molecular Medicine Tri-Conference - Feb 24 2009 10:05AM
Zacks Analyst Blog Highlights: Embarq, Sprint Nextel, CenturyTel, Regeneron Pharmaceuticals, Inc. And UAL Corporation.
Regeneron Announces Participation in a Panel Discussion at RBC Capital Markets Healthcare Conference
Regeneron Announces Presentation at the 20th Annual Piper Jaffray Healthcare Conference
Regeneron Announces Presentation at the Credit Suisse 2008 Healthcare Conference
Zacks Analyst Blog Highlights: Coca-Cola Hellenic Bottling Co., Regeneron Pharmaceuticals, Inc., Denbury Resources Inc., Kinross Gold Corp. And Trimeris, Inc. - Nov 8 2008 12:31PM
Regeneron Reports Third Quarter 2008 Financial and Operating Results
VEGF Trap-Eye Final Phase 2 Results in Age-related Macular Degeneration Presented at 2008 Retina Society Meeting
Regeneron Announces Presentation at the UBS Global Life Sciences Conference
Regeneron and Columbia University Enter Into a Strategic VelocImmune(R) Agreement to Discover Human Monoclonal Antibodies
Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
Regeneron's ARCALYST(R) (rilonacept) Reduced Incidence of Gout Flares by 81 Percent in a Phase 2 Study in Gout Patients Initiating Urate-Lowering Therapy
Regeneron Announces Webcast Presentation of Results from Phase 2 Study of ARCALYST(R) (rilonacept) in Gout Patients Initiating Urate-Lowering Therapy
Regeneron and Bayer HealthCare Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular Degeneration
Regeneron Announces Presentation at the 28th Annual Canaccord Adams Global Growth Conference
Zacks Analyst Blog Highlights: Regeneron, Sanofi-Aventis S.A., AstraZeneca, Ambac Financial and Citigroup
Regeneron Announces VelociGene(R) Agreement with Sanofi-Aventis
Regeneron Announces Presentation at BMO Capital Markets 2008 Focus on Healthcare Conference
Regeneron Reports Second Quarter 2008 Financial and Operating Results
Regeneron Announces Presentation at Jefferies 2nd Annual Healthcare Conference
Regeneron Announces Presentation at Needham Seventh Annual Biotechnology and Medical Technology Conference
Sanofi-aventis and Regeneron Update Aflibercept (VEGF Trap) Clinical Development Program in Oncology - May 27 2008 12:59AM
Regeneron Announces Presentation at Citi Investment Research Global Healthcare Conference - May 27 2008 12:56AM
Regeneron Reports First Quarter 2008 Financial and Operating Results - Jun 2 2008 2:37AM
Regeneron and Bayer HealthCare Announce Encouraging 32-Week Follow-Up Results from a Phase 2 Study of VEGF Trap-Eye in Age-Related Macular Degeneration
Regeneron Announces Presentation at Morgan Stanley Global Healthcare Unplugged Conference